THE USE OF DELAYED AND/OR SUSTAINED RELEASE VITAMIN D FORMULATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING D-VITAMINS

THE USE OF DELAYED AND/OR SUSTAINED RELEASE VITAMIN D FORMULATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING D-VITAMINS

Method of treating prostatic conditions such as prostate cancer and hyperplasia by administering 1 alpha -hydroxyprevitamin D or activated vitamin D or a combination thereof in a sustained release form or a delayed and sustained release formulation. Both the sustained release form and the delayed, s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VALLIERE CHARLES R. VALLIERE CHARLES R, KNUTSON JOYCE C. KNUTSON JOYCE C, BISHOP CHARLES W. BISHOP CHARLES W
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Method of treating prostatic conditions such as prostate cancer and hyperplasia by administering 1 alpha -hydroxyprevitamin D or activated vitamin D or a combination thereof in a sustained release form or a delayed and sustained release formulation. Both the sustained release form and the delayed, sustained release form deliver increased active vitamin D blood levels without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms, to provide the beneficial effect to the diseased prostate tissue.